Hongda Ma
Impact in
-
- Intensive Care Unit Cognitive Disorders
Papers in
-
- RNA modifications and cancer 2
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 1
- Co-authors
- Qingchun Zhao (6 shared papers)An Li (3 shared papers)Fuhai Hui (1 shared paper)Tianshu Ren (1 shared paper)Jiayi Cai (1 shared paper)Yingshi Zhang (1 shared paper)Changli Wang (4 shared papers)Fan Feng (3 shared papers)
- Journals
- Neurochemical Research (1 paper)Computers and Electronics in Agriculture (1 paper)OncoTargets and Therapy (1 paper)Environmental Toxicology and Pharmacology (1 paper)ACS Applied Materials & Interfaces (1 paper)
- Partner nations
- ChinaUnited StatesMexico
In The Last Decade
Hongda Ma
18 papers receiving 550 citations
Peers
Comparison fields: 5 of 104
- Critical Care and Intensive Care Medicine 43
- Drug Discovery 1
- Cancer Research 87
- Pharmacology 44
- Social Psychology 101
Countries citing papers authored by Hongda Ma
This map shows the geographic impact of Hongda Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongda Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongda Ma more than expected).
Fields of papers citing papers by Hongda Ma
This network shows the impact of papers produced by Hongda Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongda Ma. The network helps show where Hongda Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Hongda Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 157 | |
| 2 | 2016 | 102 | |
| 3 | 2017 | 63 | |
| 4 | 2008 | 63 | |
| 5 | 2016 | 50 | |
| 6 | 2016 | 26 | |
| 7 | 2015 | 25 | |
| 8 | 2012 | 19 | |
| 9 | Genistein promotes apoptosis of lung cancer cells through the IMPDH2/AKT1 pathway. | 2022 | 16 |
| 10 | 2015 | 13 | |
| 11 | 2020 | 12 | |
| 12 | 2023 | 6 | |
| 13 | 2010 | 4 | |
| 14 | 2018 | 3 | |
| 15 | [Human endostatin antiangiogenic gene therapy mediated by recombinant adeno-associated virus vector in nude mouse with endometriosis]. | 2010 | 3 |
| 16 | 2025 | 2 | |
| 17 | 2020 | 2 | |
| 18 | 2022 | 1 |
About Hongda Ma
Hongda Ma is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Pharmacology and Pharmacology, having authored 18 papers that have together received 567 indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (2 papers), Cancer-related Molecular Pathways (2 papers), RNA modifications and cancer (2 papers), Berberine and alkaloids research (2 papers), Drug Solubulity and Delivery Systems (1 paper), Nanoplatforms for cancer theranostics (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper) and Tree-ring climate responses (1 paper). The work is most often cited by research in Critical Care and Intensive Care Medicine (43 citations), Drug Discovery (1 citation), Cancer Research (87 citations), Pharmacology (44 citations) and Social Psychology (101 citations). Hongda Ma has collaborated with scholars based in China, United States and Mexico. Frequent co-authors include Qingchun Zhao, An Li, Fuhai Hui, Tianshu Ren, Jiayi Cai, Yingshi Zhang, Changli Wang, Fan Feng, Yongjun Wang and Tao Guo. Their work appears in journals such as Neurochemical Research, Computers and Electronics in Agriculture, OncoTargets and Therapy, Environmental Toxicology and Pharmacology and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.